Am J Transplant, Volume 19, Suppl 3 Archives - Page 26 of 214 - ATC Abstracts

2019 American Transplant Congress
The Reduced Tacrolimus Metabolism Rate and Its Association with Estimated Glomerular Filtration Rate and Interstitial Fibrosis: A Study Using Korean Organ Transplantation Registry (KOTRY) Dataset
J. Jeong¹, H. Ro², T. Koo³, J. Yang³, M. Kim⁴, S. Shin⁵, J. Park⁶, T. Ban⁷, S. Han⁸, T. Kim⁹, C. Ahn¹⁰
¹Ajou University School of Medicine, Suwon, Korea, Republic of, ²Gachon University, Incheon, Korea, Republic of, ³Seoul National University Hospital, Seoul, Korea, Republic of, ⁴Yonsei University College of Medicine, Seoul, Korea, Republic of, ⁵Asan Medical Center, Seoul, Korea, Republic of, ⁶Samsung Medical Center, Seoul, Korea, Republic of, ⁷Seoul St Mary's Hospital, Seoul, Korea, Republic of, ⁸Keimyung University School of Medicine, Daegu, Korea, Republic of, ⁹Inje University, Busan Paik Hospital, Busan, Korea, Republic of, ¹⁰Seoul National University College of Medicine, Seoul, Korea, Republic of
*Purpose: Tacrolimus is the key drug in clinical transplant, which has narrow therapeutic index. A few studies reported the association of tacrolimus metabolism rate with…
2019 American Transplant Congress
Unfavorable Donor after Cardiac Death Characteristics in Lung Transplantation: An Analysis of the UNOS Registry
A. Y. Choi¹, O. K. Jawitz², V. Raman², Y. Barac², M. S. Mulvihill², C. Moore², M. G. Hartwig²
¹Duke University School of Medicine, Durham, NC, ²Department of Surgery, Duke University Medical Center, Durham, NC
*Purpose: Despite growing evidence that donation after circulatory death (DCD) lung transplants have comparable survival outcomes and primary graft dysfunction rates to donation after brain…
2019 American Transplant Congress
REHANNA: Renal Transplants in Hepatitis C Negative Recipients with Nucleic Acid Positive Donors with Short Course Direct Acting Antiviral Prophylaxis
C. Durand, B. Barnaba, D. Brown, N. Bair, F. Naqvi, M. Bowring, D. Segev, M. Sulkowski, N. Desai
Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: To mitigate the current organ shortage and underutilization of hepatitis C-infected deceased donor (HCV D+) organs, we evaluated the use of HCV D+ kidneys…
2019 American Transplant Congress
Apparatus and Method to Facilitate In-Situ Cold Perfusion of Abdominal Organs in DCD Donors
M. Jendrisak
Gift of Hope Organ & Tissue Donor Network, Itasca, IL
*Purpose: Rapid, effective in-situ cold perfusion of the abdominal organs in the setting of donation after circulatory death (DCD) is a critical surgical task to…
2019 American Transplant Congress
What Are Factors That Can Influence The High Immunological Graft Loss Rate In Young Pancreas Transplant Recipients
A. C. Gruessner, J. Renz, S. Saggi, R. W. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Pancreas transplants (tx) are increasingly performed in older patients with type 1 diabetes mellitus. This trend may be explained by the significantly higher immunologic…
2019 American Transplant Congress
Outcomes of Total Pancreatectomyand Islet Autotransplantation, a Single Center Experience
A. Rajab¹, J. Buss¹, L. F. Lara², S. Meng³, K. Kuntz⁴, D. Conwell², P. A. Hart², K. Washburn¹
¹Transplant Surgery, The Ohio State University, Columbus, OH, ²Gastroenterology, Hepatology and Nutrition, The Ohio State University, Columbus, OH, ³Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, OH, ⁴Psychiatry and Behavioral Health, The Ohio State University, Columbus, OH
*Purpose: Patients with chronic pancreatitis (CP) suffer from severe pain that greatly reduces their quality of life and often leads to long-term narcotic therapy to…
2019 American Transplant Congress
What Do We Not Know about Long Term Liver Transplant Patients? A Look at Side Effect Burden and Medication Adherence
K. Foster¹, C. Perez¹, T. Harrison¹, H. Corbo¹, N. Patel¹, D. Taber¹, H. Meadows¹, J. Fleming¹, D. DuBay², J. McGillicuddy², N. Pilch¹
¹Department of Pharmacy Services, -Medical University of South Carolina, -Charleston, SC, ²Division of Transplant Surgery, Department of Surgery, -Medical University of South Carolina, -Charleston, SC
*Purpose: Historically our focus in transplantation has been on 1 year patient and graft outcomes. With the proposed shifts in legislation and the more recent…
2019 American Transplant Congress
Characteristics Associated with Immunosuppressant Adherence after Deceased Donor Kidney Transplant
A. R. Wilk¹, W. S. Cherikh¹, J. Maghirang¹, E. A. Witt², H. Kirkham², S. Boghani², N. Hira³, G. Pietradoni², D. K. Klassen¹
¹United Network for Organ Sharing, Richmond, VA, ²Walgreen Co, Deerfield, IL, ³AllianceRx Walgreens Prime, Orlando, FL
*Purpose: Without adherence to immunosuppressant (IS) medication, renal allografts will likely not last in transplant (TX) recipients, which may result in progressively worsened renal function…
2019 American Transplant Congress
Genomic Variations in Epstein Barr Virus are Associated with Post-Transplant Lymphoproliferative Disorder
M. Arvedson, E. Maloney, C. Esquivel, O. Martinez, S. Krams
Stanford Univ School of Med, Stanford, CA
*Purpose: Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of organ transplantation characterized by abnormal proliferation of lymphoid cells in the setting of immunosuppression.…
2019 American Transplant Congress
Effects of Major Liver Allocation Policy Changes on Waitlist Outcomes in Multivisceral Transplantation
S. Nagai¹, M. Rizzari¹, Y. Muszkat², K. Collins¹, A. Yoshida¹, S. Jafri², M. Abouljoud¹
¹Transplant and Hepatobiliary Surgeryery, Henry Ford Hospital, Detroit, MI, ²Gastroenterology, Henry Ford Hospital, Detroit, MI
*Purpose: Liver-intestine allocation is determined in the liver waitlist. This study aimed to evaluate effects of recent updates in liver allocation policy on waitlist outcomes…